DKSH has entered an agreement with Cytek Biosciences in Asia. This partnership is in line with the strategic focus of DKSH Business Unit Technology to solidify its position as a leading integrated solutions provider for the scientific instrumentation market.
Zurich, February, 28 2022– DKSH Business Unit Technology has entered a partnership with Cytek Biosciences, a leading manufacturer of flow cytometry products on a mission to advance cancer and cell biology research. DKSH will provide marketing, sales, and after-sales services in Indonesia, Malaysia, the Philippines, Thailand, and Vietnam.
Cytek Biosciences’ solutions enable scientists to obtain deep biological insights rapidly and efficiently through high-quality, high-parametric datasets. Its powerful cell analysis technique and full spectrum flow cytometry help deliver deep immune cell profiling benefits to scientists in various fields, such as pharmaceutical companies, CRO firms, and academic research institutions. Full spectrum flow cytometry can be widely applied in research areas, including drug discovery, genomic, immunoprofiling, diagnostics, research, immuno-oncology, infectious diseases, and inflammatory diseases.
“DKSH offers great market coverage in Southeast Asia and has a strong focus in the life science segment. We believe that DKSH is the right partner to help us expand the markets and meet our growth goals,” said Edmond Chua, Sales and Marketing Manager, Cytek Biosciences East Asia.
Marco Farina Senior Director, Business Development, Business Unit Technology, DKSH, commented: “With the partnership with Cytek Biosciences, DKSH is able to expand our life sciences portfolio and accelerate our growth for the business. We are excited to introduce Cytek Biosciences’ leading solutions to our customers and we are confident to grow the market, leveraging our good sales coverage, strong application support, and excellence in after-sales services.
About Cytek Biosciences
Cytek Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek’s compact, affordable instruments and wide-ranging support offerings are used by researchers and clinicians all over the world. Flow cytometry is a powerful analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis up to tens of thousands of cells per second. This technology is used in research and clinical studies with various biomedical and therapeutic applications such as investigating the role of the body’s immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients. Flow cytometry has many advantages over traditional microscopy since it enables the analysis of a greater number of cells in a fraction of the time. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. For more information, visit www.cytekbio.com.
About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 33,100 specialists, generating net sales of CHF 11.1 billion in 2021. The DKSH Business Unit Technology offers complete solutions for specialized industrial applications. With around 1,600 specialists, the Business Unit generated net sales of CHF 430.3 million in 2021. www.dksh.com/tec